These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19297276)

  • 1. Switch therapy in full-term neonates with presumed or proven bacterial infection.
    Manzoni P; Esposito S; Gallo E; Gastaldo L; Farina D; Principi N
    J Chemother; 2009 Feb; 21(1):68-73. PubMed ID: 19297276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Italian experience of sequential intravenous and oral azithromycin plus intravenous ampicillin/sulbactam in hospitalized patients with community-acquired pneumonia.
    Todisco T; Dal Farra F; Ciliberti G; Pirina P; Guelfi R; Serra G; Paris R; Mancuso I; Cepparulo M
    J Chemother; 2008 Apr; 20(2):225-32. PubMed ID: 18467250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramuscular sulbactam/ampicillin combination therapy in gynaecological and obstetric bacterial infections.
    Abbassi AF; Said A; Gaber A
    J Int Med Res; 1991; 19 Suppl 1():44A-49A. PubMed ID: 2060693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulbactam/ampicillin followed by oral treatment with sultamicillin for medical and surgical infections.
    Chang ST; Chung HY; Pai SD; Lee JH
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):175S-178S. PubMed ID: 2686917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short antibiotic prophylaxis for bacterial infections in a neonatal intensive care unit: a randomized controlled trial.
    Auriti C; Ravà L; Di Ciommo V; Ronchetti MP; Orzalesi M
    J Hosp Infect; 2005 Apr; 59(4):292-8. PubMed ID: 15749316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam).
    Coccolini F; Catena F; Ansaloni L; Ercolani G; Di Saverio S; Gazzotti F; Lazzareschi D; Pinna AD
    BMC Gastroenterol; 2011 Apr; 11():42. PubMed ID: 21501482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ampicillin-sulbactam and amikacin used as second-line antibiotics for patients with culture-negative peritonitis.
    Lam MF; Tang BS; Tse KC; Chan TM; Lai KN
    Perit Dial Int; 2008; 28(5):540-2. PubMed ID: 18708550
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulbactam/ampicillin combination in the treatment of acute and chronic lower respiratory infections.
    Bisetti A; Grassi L; Scacciacillani E; Putti P
    J Int Med Res; 1991; 19 Suppl 1():36A-43A. PubMed ID: 2060692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of sulbactam-ampicillin/sultamicillin in mixed infections.
    Moosdeen F
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S1. PubMed ID: 10526866
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulbactam/ampicillin in the treatment of pediatric infections.
    Kanra G; Secmeer G; Akalin E; Ecevit Z; Calikoglu AS; Gunel M; Tarim O
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):185S-187S. PubMed ID: 2591177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients].
    Lode H; Springsklee M
    Med Klin (Munich); 1989 May; 84(5):236-41. PubMed ID: 2661984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of sulbactam plus ampicillin in the treatment of general pediatric infections.
    Bassetti D; Solbiati M; Ravelli A; Martini A; Viola S; Burgio RG
    APMIS Suppl; 1989; 5():41-4. PubMed ID: 2660870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ampicillin and sulbactam in pediatric patients.
    Nahata MC; Vashi VI; Swanson RN; Messig MA; Chung M
    Antimicrob Agents Chemother; 1999 May; 43(5):1225-9. PubMed ID: 10223940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAIN study: a protocol for a randomised controlled trial evaluating efficacy, safety and cost-effectiveness of intravenous-to-oral antibiotic switch therapy in neonates with a probable bacterial infection.
    Keij FM; Kornelisse RF; Hartwig NG; Mauff K; Poley MJ; Allegaert K; Reiss IKM; Tramper-Stranders GA
    BMJ Open; 2019 Jul; 9(7):e026688. PubMed ID: 31289068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical evaluation of sulbactam/ampicillin in the treatment of pediatric infections.
    Huang LM; Lee CY; Lee MJ; Hsu CY; Liu CC; Hong JY; Chen JM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1989; 30(2):87-93. PubMed ID: 2637593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors participating in development of bleeding varices in portal hypertension. Part I: bacterial infection and comparison of intravenous and peroral antibiotics effects--a randomised study].
    Lata J; Juránková J; Husová L; Senkyrík M; Díte P; Dastych M; Príbramská V
    Vnitr Lek; 2004 Nov; 50(11):830-5. PubMed ID: 15648962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of an ampicillin-sulbactam combination after intravenous and intramuscular administration to neonatal calves.
    Fernández-Varón E; Escudero-Pastor E; Cárceles-Rodríguez CM
    Vet J; 2005 May; 169(3):437-43. PubMed ID: 15848786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
    Betrosian AP; Douzinas EE
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritonsillar abscess: a comparison of outpatient i.m. clindamycin and inpatient i.v. ampicillin/sulbactam following needle aspiration.
    Ozbek C; Aygenc E; Unsal E; Ozdem C
    Ear Nose Throat J; 2005 Jun; 84(6):366-8. PubMed ID: 16075861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.